Perrigo Company plc faces operational risks and high leverage while maintaining its 22-year dividend growth record. See why PRGO stock is a hold.

The market expects Perrigo (PRGO) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is ...

Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that it plans to issue its fourth quarter and fiscal year 2025 financial results on Thursday, February ...

DUBLIN, Ireland — Perrigo has plans to cut about 6% of its workforce which is slated to begin the first quarter of 2024. The over-the-counter pharmaceutical manufacturer said despite improvements in ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and ...

Which of the highest-yielding healthcare stocks are value traps or golden opportunities?

Perrigo’s performance has been mixed, with management changes, integration issues, the return of branded competitors to store shelves, and competitive pressure in the prescription topicals business.

Perrigo Company is recalling of a batch — or 16,500 cans — of powdered baby formula sold by H-E-B grocery and CVS Health stores in 12 states due to elevated levels of vitamin D, the company said in a ...

Add Yahoo as a preferred source to see more of our stories on Google. Perrigo Company is recalling of a batch — or 16,500 cans — of powdered baby formula sold by H-E-B grocery and CVS Health stores in ...